Oncotelic Therapeutics Inc (OTLC)

Currency in USD
0.0505
0.0000(0.00%)
Closed·
OTLC Scorecard
Full Analysis
Suffers from weak gross profit margins
OTLC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.05010.0550
52 wk Range
0.01700.0700
Key Statistics
Prev. Close
0.0505
Open
0.055
Day's Range
0.0501-0.055
52 wk Range
0.017-0.07
Volume
-
Average Volume (3m)
80.71K
1-Year Change
77.19%
Book Value / Share
0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OTLC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Oncotelic Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Oncotelic Therapeutics Inc Company Profile

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications. It develops antisense and small molecule injectable drugs for the treatment of cancer. The company is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. In addition, it develops CA4P for the treatment of advanced metastatic melanoma; AL-101, an intranasal drug and delivery system for intra-nasal apomorphine for the treatment of parkinson’s disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies, as well as nanoparticle products for the treatments of various cancers. The company is headquartered in Agoura Hills, California.

Compare OTLC to Peers and Sector

Metrics to compare
OTLC
Peers
Sector
Relationship
P/E Ratio
−4.7x−8.4x−0.5x
PEG Ratio
−0.100.380.00
Price/Book
2.6x3.1x2.6x
Price / LTM Sales
-375.1x3.2x
Upside (Analyst Target)
-200.6%42.0%
Fair Value Upside
Unlock5.4%6.6%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

OTLC Income Statement

FAQ

What Stock Exchange Does Oncotelic Therapeutics Trade On?

Oncotelic Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Oncotelic Therapeutics?

The stock symbol for Oncotelic Therapeutics is "OTLC."

What Is the Oncotelic Therapeutics Market Cap?

As of today, Oncotelic Therapeutics market cap is 20.62M.

What Is Oncotelic Therapeutics's Earnings Per Share (TTM)?

The Oncotelic Therapeutics EPS (TTM) is -0.01.

When Is the Next Oncotelic Therapeutics Earnings Date?

Oncotelic Therapeutics will release its next earnings report on 24 Aug 2025.

From a Technical Analysis Perspective, Is OTLC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Oncotelic Therapeutics Stock Split?

Oncotelic Therapeutics has split 2 times.

How Many Employees Does Oncotelic Therapeutics Have?

Oncotelic Therapeutics has 26 employees.

What is the current trading status of Oncotelic Therapeutics (OTLC)?

As of 30 Jul 2025, Oncotelic Therapeutics (OTLC) is trading at a price of 0.05, with a previous close of 0.05. The stock has fluctuated within a day range of 0.05 to 0.06, while its 52-week range spans from 0.02 to 0.07.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.